Salman Jabri

Title: The Innovations of Salman Jabri

Introduction

Salman Jabri is an accomplished inventor based in Morage, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit plasma kallikrein. His work is aimed at addressing various medical conditions that can benefit from such inhibition.

Latest Patents

Salman Jabri holds a patent for his invention titled "Plasma kallikrein inhibitors." This patent provides a compound of Formula (I) and pharmaceutical compositions that include one or more of these compounds. The methods outlined in the patent are designed for treating or preventing several disease states, including hereditary angioedema, uveitis, posterior uveitis, wet age-related macular edema, diabetic macular edema, diabetic retinopathy, and retinal vein occlusion. The compounds developed by Jabri are selective inhibitors of plasma kallikrein, showcasing his innovative approach to addressing complex medical issues. He has 1 patent to his name.

Career Highlights

Salman Jabri is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. His role at Merck allows him to collaborate with other experts in the field and contribute to groundbreaking research and development in pharmaceuticals.

Collaborations

One of his notable coworkers is Christopher J Sinz, with whom he collaborates on various projects within the company. Their combined expertise enhances the innovative capabilities of their team.

Conclusion

Salman Jabri's work in developing plasma kallikrein inhibitors represents a significant advancement in the treatment of various medical conditions. His contributions to the pharmaceutical industry highlight the importance of innovation in improving healthcare outcomes.